Negative regulation of thyroid stimulating hormone α and β subunit genes by thyroid hormone and its receptor
甲状腺激素及其受体对促甲状腺激素α和β亚基基因的负调控
基本信息
- 批准号:15590973
- 负责人:
- 金额:$ 0.96万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The negative regulation of thyrotropin (thyroid stimulating hormone, TSH,) production by the thyroid hormone (T3) and its receptor (TR) is the central mechanism of the pituitary-thyroid axis. We previously reported that such negative regulation is able to be observed in kidney derived CV1 cells in the presence of GATA2 and Pit1, which are the thyrotroph specific transcription factors. Using CAT-based reporter assays in CV1 cells, we have analyzed the function of the putative negative regulatory element (NRE) which has been reported to mediate the negative regulation of TSHβ gene by T3-bound TR (T3/TR). Unexpectedly, the negative regulation was maintained even in the deletion or the mutation of NRE. Further analysis revealed that the negative regulation was detected in the construct, TSHβ-D4-CAT, which possesses only Pit1 and GATA2 binding sites. Interestingly, TSHβ-D4-CAT is activated by the presence of GATA2 only and such a transactivation is specifically inhibited by T3/TR. We found that the Zn-finger of GATA2 interacts with the DNA binding domain (DBD) of TR in a T3 independent fashion, suggesting that the negative regulation of TSHβ promoter is mediated by the cross-talk between IR and GATA2. The suppression by T3/TR was recovered by the overexpression of dominant negative-type TR associated protein (TRAP) 220 indicating an essential participation of TRAP220 in the negative regulation of TSHβ gene. Chromatin immunoprecipitation assay with thyrotroph cell line, TαT1, showed that the acetylation of histone H4 is reduced by the addition of T3. In conclusion, the present study suggests (1) GATA2 is the major transcriptional activator for TSHβ promoter (2) T3/TR interacts and interferes with GATA2 (3) TRAP220 that lacks intrinsic histone acetyltransferase activity and the alteration of histone acetylation are involved in the mechanism of the negative regulation of TSHβ gene.
甲状腺激素(T3)及其受体(TR)对促甲状腺激素(促甲状腺激素,TSH)产生的负调节是垂体-甲状腺轴的中心机制。我们以前报道过,这种负调控是能够观察到在肾脏衍生的CV1细胞的存在下,GATA 2和Pit 1,这是促甲状腺细胞特异性转录因子。利用CAT报告基因分析技术,对T3结合TR(T3/TR)介导TSHβ基因负调控的负调控元件(NRE)的功能进行了研究。出乎意料的是,即使在NRE的缺失或突变中,负调控也保持不变。进一步的分析表明,在只有Pit 1和GATA 2结合位点的构建体TSHβ-D4-CAT中检测到负调控。有趣的是,TSHβ-D4-CAT仅被GATA 2激活,这种反式激活被T3/TR特异性抑制。我们发现GATA 2的锌指与TR的DNA结合域(DBD)以T3非依赖性方式相互作用,提示TSHβ启动子的负调控是由IR和GATA 2之间的相互作用介导的。T3/TR的抑制可通过显性负型TR相关蛋白(TRAP)220的过度表达而恢复,表明TRAP 220参与了TSHβ基因的负调控。用促甲状腺细胞系TαT1进行的染色质免疫沉淀试验表明,组蛋白H4的乙酰化被T3的加入所减少。结论:(1)GATA 2是TSHβ启动子的主要转录激活因子;(2)T3/TR与GATA 2相互作用并干扰;(3)缺乏内源性组蛋白乙酰转移酶活性的TRAP 220和组蛋白乙酰化改变参与了TSHβ基因负调控的机制。
项目成果
期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamagoe S, Kanno T, Kanno Y, Sasaki S S et al.: "Interaction of histone acetylases and deacetylases in vivo"Mol Cell Biol.. 23. 1025-1033 (2003)
Yamagoe S、Kanno T、Kanno Y、Sasaki S S 等:“体内组蛋白乙酰酶和脱乙酰酶的相互作用”Mol Cell Biol.. 23. 1025-1033 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Interaction of histone Acetylases and deacetylases in vivo
- DOI:10.1128/mcb.23.3.1025-1033.2003
- 发表时间:2003-02-01
- 期刊:
- 影响因子:5.3
- 作者:Yamagoe, S;Kanno, T;Ozato, K
- 通讯作者:Ozato, K
Natsume H, Sasaki S, Kitagawa M et al.: "Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone"Biochem Biophys Res Commun. 309. 408-413 (2003)
Natsume H、Sasaki S、Kitakawa M 等人:“β-连环蛋白/Tcf-1 介导的细胞周期蛋白 D1 启动子反式激活受到甲状腺激素的负调节”Biochem Biophys Res Commun。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
甲状腺ホルモンとその受容体による甲状腺刺激ホルモンα、β鎖への負の転写調節
甲状腺激素及其受体对促甲状腺激素α和β链的负转录调节
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:佐々木茂和;松下明生;中野桂子他
- 通讯作者:中野桂子他
Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by tbvroid hormone receptors : study with a new experimental system us.
tbvroid激素受体对促甲状腺素β基因的甲状腺激素依赖性负调节:使用新的实验系统进行研究。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Nakano K;Matsushita A;Sasaki S et al.
- 通讯作者:Sasaki S et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SASAKI Shigekazu其他文献
SASAKI Shigekazu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SASAKI Shigekazu', 18)}}的其他基金
The molecular mechanism of the linear-log relation between thyrotropin synthesis and T3
促甲状腺素合成与T3线性对数关系的分子机制
- 批准号:
24590689 - 财政年份:2012
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The study of the negative regulation of thyrotropin b by thyroid hormone and its receptor
甲状腺激素及其受体对促甲状腺素b负调节作用的研究
- 批准号:
12671077 - 财政年份:2000
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Hypothalamic regulation by thyroid hormone receptor phosphorylation
甲状腺激素受体磷酸化对下丘脑的调节
- 批准号:
10717820 - 财政年份:2023
- 资助金额:
$ 0.96万 - 项目类别:
Thyroid hormone receptor β1 agonist therapy for the treatment of bone marrow adiposity in aging and obesity
甲状腺激素受体β1激动剂疗法治疗衰老和肥胖症中的骨髓肥胖
- 批准号:
9893266 - 财政年份:2020
- 资助金额:
$ 0.96万 - 项目类别:
Establishment of treatment target for MS: Thyroid hormone receptor beta1 signaling is critically involved in the EAE pathogenesis
MS治疗目标的确立:甲状腺激素受体β1信号传导在EAE发病机制中发挥重要作用
- 批准号:
16K09704 - 财政年份:2016
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role Of Thyroid Hormone Receptor Signaling In White Adipose Tissue Mediated Adaptive Thermogenesis
甲状腺激素受体信号在白色脂肪组织介导的适应性产热中的作用
- 批准号:
9136146 - 财政年份:2015
- 资助金额:
$ 0.96万 - 项目类别:
Thyroid hormone receptor protects against kidney injury by inhibiting tubular cell apoptosis
甲状腺激素受体通过抑制肾小管细胞凋亡来防止肾损伤
- 批准号:
15K09424 - 财政年份:2015
- 资助金额:
$ 0.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Thyroid Hormone Receptor Isoform-Specific Actions
甲状腺激素受体亚型特异性作用
- 批准号:
9222005 - 财政年份:2014
- 资助金额:
$ 0.96万 - 项目类别:
Thyroid Hormone Receptor Isoform-Specific Actions
甲状腺激素受体亚型特异性作用
- 批准号:
8638458 - 财政年份:2014
- 资助金额:
$ 0.96万 - 项目类别:
Thyroid Hormone Receptor Isoforms in Skeletal Muscle
骨骼肌中的甲状腺激素受体亚型
- 批准号:
9058050 - 财政年份:2013
- 资助金额:
$ 0.96万 - 项目类别:
Thyroid Hormone Receptor Isoforms in Skeletal Muscle
骨骼肌中的甲状腺激素受体亚型
- 批准号:
8581286 - 财政年份:2013
- 资助金额:
$ 0.96万 - 项目类别:
Thyroid Hormone Receptor Isoforms in Skeletal Muscle
骨骼肌中的甲状腺激素受体亚型
- 批准号:
8840942 - 财政年份:2013
- 资助金额:
$ 0.96万 - 项目类别: